{"id":605366,"date":"2026-09-04T06:48:16","date_gmt":"2026-09-04T06:48:16","guid":{"rendered":"https:\/\/www.newsbeep.com\/il\/605366\/"},"modified":"2026-09-04T06:48:16","modified_gmt":"2026-09-04T06:48:16","slug":"coeliac-disease-sufferers-eat-gluten-with-few-symptoms-in-promising-israeli-drug-trial","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/il\/605366\/","title":{"rendered":"Coeliac Disease sufferers eat gluten with few symptoms in promising Israeli drug trial"},"content":{"rendered":"\n<p>In the study, the 50 were randomly assigned to receive a injection of the antibody treatment\u00a0or a placebo.<\/p>\n<p>Two weeks after receiving a single dose, the participants were instructed to consume gluten daily for six weeks.<\/p>\n<p>A single injection of TEV-408 significantly reduced damage and inflammation in the small intestine compared with a placebo after eight weeks, Teva said according to Reuters.<\/p>\n<p>Patients also reported fewer digestive symptoms, while \u200cno \u2060new safety concerns were identified, the company said.<\/p>\n<p>That result\u00a0met the main goal of the\u00a0mid-stage trial.<\/p>\n<p>In an announcement, Teva, wrote: \u201c[The trail] showed statistically significant and clinically meaningful prevention of gluten-induced intestinal damage&#8230; showed a favourable effect on intestinal inflammation&#8230; [and] demonstrated lower [gerontological] symptoms.\u201d<\/p>\n<p>Eric Hughes, the executive vice president, head of research and development, and chief medical officer of Teva, hailed the findings, saying: \u201cA strict gluten-free diet has long been the only option for people living with Coeliac disease. Yet, even with strict adherence to a gluten-free diet, many continue to experience symptoms, intestinal damage and a significant impact on their daily lives.<\/p>\n<p>\u201cThese results underscore the potential to move beyond managing gluten exposure and address Coeliac disease at its biological source.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"In the study, the 50 were randomly assigned to receive a injection of the antibody treatment\u00a0or a placebo.&hellip;\n","protected":false},"author":2,"featured_media":605367,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[42,2409,43,40,38,41,39],"class_list":["post-605366","post","type-post","status-publish","format-standard","has-post-thumbnail","category-headlines","tag-headlines","tag-medicine","tag-news","tag-top-news","tag-top-stories","tag-topnews","tag-topstories"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/605366","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/comments?post=605366"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/605366\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media\/605367"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media?parent=605366"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/categories?post=605366"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/tags?post=605366"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}